Symptomatic Control of Neuroendocrine Tumors with Everolimus

被引：0
作者：
Bainbridge, H. [1 ]
Larbi, E. [2 ]
Middleton, G. [2 ]
机构：
[1] Royal Marsden Hosp, London SW3 6JJ, England
[2] Royal Surrey Cty Hosp, Guildford, Surrey, England
来源：
NEUROENDOCRINOLOGY | 2012年 / 96卷
关键词：
neuroendocrine; carcinoid; everolimus; symptom;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [1] Symptomatic Control of Neuroendocrine Tumours with Everolimus
    Hannah E. Bainbridge
    Emmanuel Larbi
    Gary Middleton
    Hormones and Cancer, 2015, 6 : 254 - 259
  • [2] Everolimus in the treatment of neuroendocrine tumors of the respiratory and gastroenteropancreatic systems
    Flaum, Nicola
    Valle, Juan W.
    Mansoor, Wasat
    McNamara, Mairead G.
    FUTURE ONCOLOGY, 2016, 12 (22) : 2561 - 2578
  • [3] Everolimus for the treatment of pancreatic neuroendocrine tumors
    Feldmann, Georg
    Bisht, Savita
    Schuette, Ute
    Haarmann, Jens
    Brossart, Peter
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (14) : 2073 - 2084
  • [4] Role of everolimus in pancreatic neuroendocrine tumors
    Goldstein, Robert
    Meyer, Tim
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (11) : 1653 - 1665
  • [5] Everolimus in the treatment of patients with advanced pancreatic neuroendocrine tumors: latest findings and interpretations
    Liu, Eric
    Marincola, Paula
    Oberg, Kjell
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2013, 6 (05) : 412 - 419
  • [6] Emerging use of everolimus in the treatment of neuroendocrine tumors
    Gajate, Pablo
    Martinez-Saez, Olga
    Alonso-Gordoa, Teresa
    Grande, Enrique
    CANCER MANAGEMENT AND RESEARCH, 2017, 9 : 215 - 224
  • [7] Everolimus in the Treatment of Neuroendocrine Tumors: Lights and Shadows
    Medici, Bianca
    Caffari, Eugenia
    Maculan, Yuri
    Benatti, Stefania
    Piacentini, Federico
    Dominici, Massimo
    Gelsomino, Fabio
    BIOMEDICINES, 2025, 13 (02)
  • [8] Opportunist Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study
    Mauro, C.
    De Jesus, V
    Nunez, J. E.
    Costa, F.
    Barros, M.
    Riechelmann, R.
    NEUROENDOCRINOLOGY, 2019, 108 : 173 - 173
  • [9] Everolimus in the treatment of renal cell carcinoma and neuroendocrine tumors
    Chan, Hiu-yan
    Grossman, Ashley B.
    Bukowski, Ronald M.
    ADVANCES IN THERAPY, 2010, 27 (08) : 495 - 511
  • [10] Efficacy and Safety of Everolimus in Metastatic Gastroenteropancreatic Neuroendocrine Tumors
    Ambrosio, M. R.
    Guerra, A.
    Lupo, S.
    Bondanelli, M.
    Sartori, S.
    Pansini, G.
    Degli Uberti, E.
    Zatelli, M. C.
    NEUROENDOCRINOLOGY, 2012, 96 : 17 - 18
12345